Literature DB >> 32954685

Psychosis-spectrum experiences linked to specific psychotherapy readiness domains among psychiatrically hospitalized adolescents.

Elizabeth C Thompson1,2,3, Anthony Spirito1, Jiayin Sperry Saarinen1, Jennifer C Wolff1,2,3.   

Abstract

AIM: Early psychosocial treatment for psychosis-spectrum symptoms has been linked to positive outcomes, whereas delayed treatment is associated with poorer prognosis. Thus, there is a critical need to bolster psychotherapy engagement efforts, particularly among high-risk groups and during high-risk periods, in order to maximize recovery. This study explores the relation between psychosis-spectrum symptoms and psychotherapy readiness among psychiatrically hospitalized adolescents, a foundational step for developing more effective psychotherapy engagement approaches for this population.
METHODS: Adolescents (n = 704; 12-18 years) who were admitted to a psychiatric inpatient unit completed the Readiness for Psychotherapy Index (RPI), a psychosis-spectrum questionnaire (PRIME Screen), and a brief diagnostic interview at intake. Correlational patterns and regression analyses were used to explore associations between variables.
RESULTS: The PRIME Screen was negatively associated with the RPI Openness subscale and positively associated with the Distress subscale, beyond the effects of demographics (ie, age, sex, race) and psychiatric diagnoses.
CONCLUSIONS: Results indicate that the RPI probes multiple facets of psychotherapy readiness that have unique associations with psychosis-spectrum experiences. Adolescents with higher PRIME scores endorsed greater mental health-related distress and lower levels of openness to psychotherapy. These psychotherapy readiness factors warrant further exploration, as they may be significant barriers or facilitators to engaging adolescents with psychosis-spectrum symptoms in much needed early treatment services.
© 2020 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  PRIME screen; adolescents; psychiatric hospital; psychosis-spectrum; psychotherapy readiness

Mesh:

Year:  2020        PMID: 32954685      PMCID: PMC7981284          DOI: 10.1111/eip.13040

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.721


  36 in total

1.  Cronbach's alpha.

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  1997-02-22

2.  EPA guidance on the early intervention in clinical high risk states of psychoses.

Authors:  S J Schmidt; F Schultze-Lutter; B G Schimmelmann; N P Maric; R K R Salokangas; A Riecher-Rössler; M van der Gaag; A Meneghelli; M Nordentoft; M Marshall; A Morrison; A Raballo; J Klosterkötter; S Ruhrmann
Journal:  Eur Psychiatry       Date:  2015-03-03       Impact factor: 5.361

3.  Externalized attributional bias in the Ultra High Risk (UHR) for psychosis population.

Authors:  Andrew Thompson; Alicia Papas; Cali Bartholomeusz; Barnaby Nelson; Alison Yung
Journal:  Psychiatry Res       Date:  2012-11-21       Impact factor: 3.222

4.  Treatment outcomes and associations in an adolescent-specific early intervention for psychosis service.

Authors:  Alice Thomson; Helen Griffiths; Rebecca Fisher; Robert McCabe; Sue Abbott-Smith; Matthias Schwannauer
Journal:  Early Interv Psychiatry       Date:  2019-01-28       Impact factor: 2.732

Review 5.  Duration of untreated illness as a key to early intervention in schizophrenia: A review.

Authors:  Andrea Murru; Bernardo Carpiniello
Journal:  Neurosci Lett       Date:  2016-10-04       Impact factor: 3.046

Review 6.  Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis.

Authors:  Paolo Fusar-Poli; Matteo Rocchetti; Alberto Sardella; Alessia Avila; Martina Brandizzi; Edgardo Caverzasi; Pierluigi Politi; Stephan Ruhrmann; Philip McGuire
Journal:  Br J Psychiatry       Date:  2015-09       Impact factor: 9.319

7.  Emotional and symptomatic reactivity to stress in individuals at ultra-high risk of developing psychosis.

Authors:  J E Palmier-Claus; G Dunn; S W Lewis
Journal:  Psychol Med       Date:  2011-11-09       Impact factor: 7.723

8.  Making sense of Cronbach's alpha.

Authors:  Mohsen Tavakol; Reg Dennick
Journal:  Int J Med Educ       Date:  2011-06-27

9.  Real-world effectiveness of antipsychotic treatment in psychosis prevention in a 3-year cohort of 517 individuals at clinical high risk from the SHARP (ShangHai At Risk for Psychosis).

Authors:  TianHong Zhang; LiHua Xu; XiaoChen Tang; YanYan Wei; Qiang Hu; YeGang Hu; HuiRu Cui; YingYing Tang; Li Hui; ChunBo Li; LiPing Cao; Zheng Lu; JiJun Wang
Journal:  Aust N Z J Psychiatry       Date:  2020-05-21       Impact factor: 5.744

10.  Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.

Authors:  Anthony P Morrison; Heather Law; Lucy Carter; Rachel Sellers; Richard Emsley; Melissa Pyle; Paul French; David Shiers; Alison R Yung; Elizabeth K Murphy; Natasha Holden; Ann Steele; Samantha E Bowe; Jasper Palmier-Claus; Victoria Brooks; Rory Byrne; Linda Davies; Peter M Haddad
Journal:  Lancet Psychiatry       Date:  2018-04-05       Impact factor: 27.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.